What the operation does
A wide local excision — commonly called a lumpectomy and also known as breast-conserving surgery — removes the cancer together with a rim of healthy tissue around it, while leaving the rest of the breast in place. It is the most common operation for early breast cancer in the UK, and for the cancers it is used to treat it offers the same long-term survival as mastectomy.
The aim is twofold: remove the cancer completely (a clear margin of healthy tissue all the way around) and preserve a natural, symmetrical-looking breast. Oncoplastic techniques — which reshape the breast as part of the cancer operation — are used routinely at Breastory to protect the cosmetic outcome, particularly where the cancer is larger, deeper, or in a part of the breast that would otherwise leave a visible defect.
Who it’s suitable for
Breast-conserving surgery is usually suitable when:
- The cancer is confined to one area of the breast (not multifocal across widely separated areas)
- The cancer is small enough, relative to the size of the breast, that removal leaves enough tissue for a good cosmetic outcome
- Radiotherapy after surgery is safe for you (breast-conserving surgery almost always requires radiotherapy afterwards)
- You are willing and able to attend radiotherapy appointments
Breast-conserving surgery may not be the right choice — or may not be your preference — when:
- The cancer is large in relation to the breast
- There is more than one cancer in separate areas of the breast
- You cannot have radiotherapy (for example because of prior radiation to the same area)
- You prefer a mastectomy for personal, genetic, or follow-up reasons
Neither option is “better” — they are different, and for the cancers that can be treated with either, the long-term survival is the same.
Oncoplastic techniques — why they matter
A simple lumpectomy removes the tumour and closes the gap. In a small cancer in a large breast, that may be all that is needed. When a larger proportion of the breast volume needs to be removed (often quoted as around 20% or more in specialist practice, though thresholds vary) — or when the cancer sits in a cosmetically sensitive part of the breast (for example near the cleavage or just below the nipple) — a simple excision risks leaving a visible dent or distortion. In these cases an oncoplastic reshape is planned from the start.
Oncoplastic techniques solve this by reshaping the breast as part of the same operation:
- Oncoplastic lumpectomy with local tissue rearrangement — the surrounding breast tissue is mobilised and reshaped to fill the defect.
- Therapeutic mammoplasty — the cancer is removed using a standard breast-reduction pattern of incisions, so the operation is effectively a reduction and a cancer excision in one. Often combined with a matching reduction on the other side for symmetry.
- Volume-replacement flaps — a small flap of tissue from elsewhere (for example from the side of the chest) is used to fill the defect.
These techniques allow bigger excisions to be done without losing shape, and they often let breast-conserving surgery be offered to women who would otherwise have been advised to have a mastectomy.
Margins and re-excision
Every specimen is examined under the microscope after surgery to confirm that the cancer has been removed with a clear margin of healthy tissue all the way around. In UK practice, around 15–20% of women need a small follow-up operation (a re-excision) because the microscope shows the cancer was a little too close to the cut edge in one place. This is a known and expected part of breast-conserving surgery, not a sign that anything has gone wrong. We will discuss this with you before your first operation so it is never a surprise. If a re-excision is needed, it does not change the long-term outcome of your cancer treatment
Re-excision is discussed openly at your first consultation so it is not a surprise if it is needed. A re-excision does not change the long-term outcome of your cancer treatment, provided the second operation achieves a clear margin. It is a standard and expected part of breast-conserving surgery.
What happens after surgery
- Histology MDT review — the final pathology (cancer type, grade, receptor status, margins, lymph nodes) is discussed at a multidisciplinary team meeting.
- Adjuvant treatment plan — radiotherapy almost always, and sometimes chemotherapy, hormone therapy, or targeted therapy depending on the cancer’s biology.
- Follow-up — clinic review at two weeks and six weeks after surgery, then annual mammography (and MRI where indicated) for surveillance, with clinic review at least annually for the first five years and then as agreed.